哈藥股份(600664.SH):擬462萬元投建哈藥六廠南直路廠區公用工程改造項目
格隆匯8月22日丨哈藥股份(600664.SH)公佈,公司分公司哈藥六廠南直路廠區版畫博物館於2024年初正式對外開放,地址位於哈爾濱市道外區南直路326號。哈藥六廠南直路廠區搬遷後處於閒置狀態,為盤活資產、提高資產使用效率,根據公司對該廠區的整體規劃,完善哈藥六廠南直路廠區綜合型文旅小鎮基礎設施,公司計劃實施南直路廠區公共工程改造項目建設,在最大程度利用現有基礎配套設施的基礎上,通過對廠區公用工程系統進行改造,以滿足該廠區基本商業運行需求。本項目規劃建設預計投資總額為462萬元,資金來源於哈藥六廠自有資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.